Real-time Estimate
Tradegate
07:15:29 23/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.354
EUR
|
+1.72%
|
|
-8.56%
|
-57.52%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
103.1
|
184.5
|
105.7
|
79.33
|
33.83
|
-
|
-
|
Enterprise Value (EV)
1 |
103.1
|
184.5
|
105.7
|
79.33
|
33.83
|
33.83
|
33.83
|
P/E ratio
|
-9.14
x
|
-10.8
x
|
-7.61
x
|
-4.1
x
|
-1.19
x
|
-1.23
x
|
-0.95
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1,054
x
|
2,044
x
|
591
x
|
145
x
|
31
x
|
13.8
x
|
3.14
x
|
EV / Revenue
|
1,054
x
|
2,044
x
|
591
x
|
145
x
|
31
x
|
13.8
x
|
3.14
x
|
EV / EBITDA
|
-13.3
x
|
-14.4
x
|
-5.51
x
|
-4.09
x
|
-1.27
x
|
-1.37
x
|
-1.04
x
|
EV / FCF
|
-1,24,72,645
x
|
-1,15,06,046
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
38,891
|
44,999
|
64,459
|
65,026
|
65,058
|
-
|
-
|
Reference price
2 |
2.650
|
4.100
|
1.640
|
1.220
|
0.5200
|
0.5200
|
0.5200
|
Announcement Date
|
30/04/21
|
02/05/22
|
11/04/23
|
29/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
0.0978
|
0.0903
|
0.1789
|
0.5464
|
1.092
|
2.457
|
10.78
|
EBITDA
1 |
-7.768
|
-12.84
|
-19.18
|
-19.4
|
-26.62
|
-24.71
|
-32.62
|
EBIT
1 |
-10.06
|
-16.06
|
-22.31
|
-22.02
|
-27.71
|
-26.89
|
-35.36
|
Operating Margin
|
-10,286.91%
|
-17,794.66%
|
-12,472.67%
|
-4,029.46%
|
-2,537.64%
|
-1,094.51%
|
-327.85%
|
Earnings before Tax (EBT)
1 |
-7.886
|
-16.65
|
-13.35
|
-19.01
|
-28.26
|
-27.44
|
-35.9
|
Net income
1 |
-7.886
|
-16.65
|
-13.35
|
-19.01
|
-28.26
|
-27.44
|
-35.9
|
Net margin
|
-8,062.54%
|
-18,446.63%
|
-7,461.48%
|
-3,478.29%
|
-2,587.64%
|
-1,116.73%
|
-332.91%
|
EPS
2 |
-0.2900
|
-0.3800
|
-0.2156
|
-0.2979
|
-0.4370
|
-0.4230
|
-0.5460
|
Free Cash Flow
|
-8.263
|
-16.03
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-8,448%
|
-17,763.13%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/04/21
|
02/05/22
|
11/04/23
|
29/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
0.0247
|
0.0255
|
0.0195
|
0.0559
|
0.0773
|
0.1503
|
0.1825
|
0.1184
|
0.0984
|
0.1342
|
0.273
|
0.273
|
0.273
|
0.41
|
0.41
|
EBITDA
1 |
-3.771
|
-4.213
|
-4.991
|
-4.979
|
-
|
-4.666
|
-4.146
|
-5.165
|
-5.573
|
-5.288
|
-6.689
|
-6.689
|
-6.689
|
-6.279
|
-6.279
|
EBIT
1 |
-5.504
|
-4.823
|
-6.107
|
-5.815
|
0.655
|
-5.076
|
-4.38
|
-6.062
|
-6.626
|
-6.34
|
-6.962
|
-6.962
|
-6.962
|
-6.825
|
-6.825
|
Operating Margin
|
-22,308.8%
|
-18,915.02%
|
-31,271.27%
|
-10,405.58%
|
847.7%
|
-3,377.18%
|
-2,399.84%
|
-5,121.56%
|
-6,734.08%
|
-4,723.22%
|
-2,550.18%
|
-2,550.18%
|
-2,550.18%
|
-1,664.63%
|
-1,664.63%
|
Earnings before Tax (EBT)
1 |
-5.517
|
-6.449
|
-0.3663
|
-0.8185
|
-
|
-4.444
|
-6.662
|
-0.4731
|
-7.484
|
-2.896
|
-7.098
|
-7.098
|
-7.098
|
-6.962
|
-6.962
|
Net income
1 |
-5.517
|
-6.449
|
-0.3663
|
-0.8185
|
-
|
-4.444
|
-6.662
|
-0.4731
|
-7.484
|
-2.896
|
-7.098
|
-7.098
|
-7.098
|
-6.962
|
-6.962
|
Net margin
|
-22,363.8%
|
-25,290.47%
|
-1,875.58%
|
-1,464.8%
|
-
|
-2,956.87%
|
-3,650.3%
|
-399.66%
|
-7,605.67%
|
-2,157.7%
|
-2,600%
|
-2,600%
|
-2,600%
|
-1,698.05%
|
-1,698.05%
|
EPS
2 |
-0.1300
|
-0.1100
|
-0.0100
|
-0.0100
|
-0.0539
|
-0.0682
|
-0.1087
|
-0.0137
|
-0.1219
|
-0.0410
|
-0.1090
|
-0.1090
|
-0.1090
|
-0.1090
|
-0.1090
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
02/05/22
|
30/05/22
|
24/08/22
|
15/11/22
|
11/04/23
|
25/05/23
|
30/08/23
|
14/11/23
|
29/03/24
|
14/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-8.26
|
-16
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/04/21
|
02/05/22
|
11/04/23
|
29/03/24
|
-
|
-
|
-
|
Last Close Price
0.52
CAD Average target price
3.875
CAD Spread / Average Target +645.19% Consensus |
1st Jan change
|
Capi.
|
---|
| -6.90% | 14.44B | | -40.72% | 2.71B | | -15.01% | 2.4B | | -14.64% | 1.42B | | -.--% | 1.12B | | +89.74% | 501M | | +27.01% | 270M | | -11.15% | 204M | | +7.41% | 195M |
Medical Imaging Systems
|